Decoding the Matrix: Instructive Roles of Proteoglycan Receptors

Biochemistry

Volumn 54, Issue 30, 2015, Pages 4583-4598

  Neill, Thomas ^a   Schaefer, Liliana ^b   Iozzo, Renato V ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELL DEATH; CELL MEMBRANES; ENZYME ACTIVITY; LIGANDS;

CHRONIC INFLAMMATORY DISEASE; EXTRACELLULAR MATRICES; HEPARAN SULFATE PROTEOGLYCANS; HIERARCHICAL INFORMATION; IMMUNOLOGICAL RESPONSE; PATHOLOGICAL CONDITIONS; RECEPTOR TYROSINE KINASE; TRANS-MEMBRANE PROTEINS;

GLYCOPROTEINS;

AGRIN; BIGLYCAN; CELL SURFACE RECEPTOR; COLLAGEN; DECORIN; ENDOSTATIN; HEPARAN SULFATE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MEMBRANE PROTEIN; PERLECAN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; SOMATOMEDIN C RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; VASCULOTROPIN RECEPTOR 2; SCLEROPROTEIN;

ANGIOGENESIS; ARTICLE; AUTOPHAGY; BASEMENT MEMBRANE; CARCINOGENESIS; CELL FUNCTION; CRYSTAL STRUCTURE; HUMAN; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; PHENOTYPE; PRIORITY JOURNAL; ANIMAL; CELL TRANSFORMATION; EXTRACELLULAR MATRIX; IMMUNOLOGY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; CELL TRANSFORMATION, NEOPLASTIC; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; INFLAMMATION; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 84938635144     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/acs.biochem.5b00653     Document Type: Article

References (212)

1. Hynes, R. O. (2007) Cell-matrix adhesion in vascular development J. Thromb. Haemostasis 5 (Suppl.1) 32-40 10.1111/j.1538-7836.2007.02569.x
2. Iozzo, R. V., Zoeller, J. J., and Nyström, A. (2009) Basement membrane proteoglycans: Modulators par excellence of cancer growth and angiogenesis Mol. Cells 27, 503-513 10.1007/s10059-009-0069-0
3. Iozzo, R. V. and Sanderson, R. D. (2011) Proteoglycans in cancer biology, tumour microenvironment and angiogenesis J.Cell.Mol.Med. 15, 1013-1031 10.1111/j.1582-4934.2010.01236.x
4. Goldoni, S. and Iozzo, R. V. (2008) Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs Int. J. Cancer 123, 2473-2479 10.1002/ijc.23930
5. Merline, R., Nastase, M. V., Iozzo, R. V., and Schaefer, L. (2012) Small leucine-rich proteoglycans: Multifunctional signaling effectors. In Extracellular Matrix: Pathobiology and Signaling (Karamanos, N., Ed.) pp 185-196, Walter de Gruyter GmbH & Co. KG, Berlin.
6. Iozzo, R. V. and Schaefer, L. (2015) Proteoglycan form and function: A comprehensive nomenclature of proteoglycans Matrix Biol. 42, 11-55 10.1016/j.matbio.2015.02.003
7. Iozzo, R. V., Goldoni, S., Berendsen, A., and Young, M. F. (2011) Small leucine-rich proteoglycans. In Extracellular Matrix: An Overview (Mecham, R. P., Ed.) pp 197-231, Springer, Berlin.
8. Schaefer, L. (2014) Proteoglycans, key regulators of cell-matrix dynamics Matrix Biol. 35, 1-2 10.1016/j.matbio.2014.05.001
9. Anders, H. J. and Schaefer, L. (2014) Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis J. Am. Soc. Nephrol. 25, 1387-1400 10.1681/ASN.2014010117
10. Bilandzic, M., Wang, Y., Ahmed, N., Luwor, R. B., Zhu, H. J., Findlay, J. K., and Stenvers, K. L. (2014) Betaglycan blocks metastatic behaviors in human granulosa cell tumors by suppressing NFkappaB-mediated induction of MMP2 Cancer Lett. 354, 107-114 10.1016/j.canlet.2014.07.039
11. Goldoni, S., Owens, R. T., McQuillan, D. J., Shriver, Z., Sasisekharan, R., Birk, D. E., Campbell, S., and Iozzo, R. V. (2003) Biologically active decorin is a monomer in solution J. Biol. Chem. 279, 6606-6612 10.1074/jbc.M310342200
12. Iozzo, R. V., Moscatello, D., McQuillan, D. J., and Eichstetter, I. (1999) Decorin is a biological ligand for the epidermal growth factor receptor J. Biol. Chem. 274, 4489-4492 10.1074/jbc.274.8.4489
13. Theocharis, A. D., Tzanakakis, G., and Karamanos, N. K. (2010) Proteoglycans in health and disease: Novel proteoglycan roles in malignancy and their pharmacological targeting FEBS J. 277, 3904-3923 10.1111/j.1742-4658.2010.07800.x
14. Neill, T., Schaefer, L., and Iozzo, R. V. (2012) Decorin, a guardian from the matrix Am. J. Pathol. 181, 380-387 10.1016/j.ajpath.2012.04.029
15. Schaefer, L. and Iozzo, R. V. (2008) Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction J. Biol. Chem. 283, 21305-21309 10.1074/jbc.R800020200
16. Iozzo, R. V. and Schaefer, L. (2010) Proteoglycans in health and disease: Novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans FEBS J. 277, 3864-3875 10.1111/j.1742-4658.2010.07797.x
17. Iozzo, R. V. and Karamanos, N. (2010) Proteoglycans in health and disease: emerging concepts and future directions FEBS J. 277, 3863 10.1111/j.1742-4658.2010.07796.x
18. Neill, T., Schaefer, L., and Iozzo, R. V. (2015) An oncosuppressive role for decorin Mol.Cell.Oncol. 2, e975645 10.4161/23723556.2014.975645
19. Neill, T., Schaefer, L., and Iozzo, R. V. (2014) Instructive roles of extracellular matrix on autophagy Am. J. Pathol. 184, 2146-2153 10.1016/j.ajpath.2014.05.010
20. Neill, T., Torres, A. T., Buraschi, S., and Iozzo, R. V. (2013) Decorin has an appetite for endothelial cell autophagy Autophagy 9, 1626-1628 10.4161/auto.25881
21. Reese, S. P., Underwood, C. J., and Weiss, J. A. (2013) Effects of decorin proteoglycan on fibrillogenesis, ultrastructure, and mechanics of type I collagen gels Matrix Biol. 32, 414-423 10.1016/j.matbio.2013.04.004
22. Järveläinen, H., Puolakkainen, P., Pakkanen, S., Brown, E. L., Höök, M., Iozzo, R. V., Sage, H., and Wight, T. N. (2006) A role for decorin in cutaneous wound healing and angiogenesis Wound Rep.Reg. 14, 443-452 10.1111/j.1743-6109.2006.00150.x
23. Baghy, K., Iozzo, R. V., and Kovalszky, I. (2012) Decorin-TGFβ axis in hepatic fibrosis and cirrhosis J. Histochem. Cytochem. 60, 262-268 10.1369/0022155412438104
24. Nikolovska, K., Renke, J. K., Jungmann, O., Grobe, K., Iozzo, R. V., Zamfir, A. D., and Seidler, D. G. (2014) A decorin-deficient matrix affects skin chondroitin/dermatan sulfate levels and keratinocyte function Matrix Biol. 35, 91-102 10.1016/j.matbio.2014.01.003
25. Marchica, C. L., Pinelli, V., Borges, M., Zummer, J., Narayanan, V., Iozzo, R. V., and Ludwig, M. S. (2011) A role for decorin in a murine model of allergen-induced asthma Am. J. Physiol. 300, L863-L873 10.1152/ajplung.00300.2009
26. Seidler, D. G., Mohamed, N. A., Bocian, C., Stadtmann, A., Hermann, S., Schäfers, K., Schäfers, M., Iozzo, R. V., Zarbock, A., and Götte, M. (2011) The role for decorin in delayed-type hypersensitivity J. Immunol. 187, 6108-6199 10.4049/jimmunol.1100373
27. Merline, R., Lazaroski, S., Babelova, A., Tsalastra-Greul, W., Pfeilschifter, J., Schluter, K. D., Gunther, A., Iozzo, R. V., Schaefer, R. M., and Schaefer, L. (2009) Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration J. Physiol. Pharmacol. 60 (Suppl. 4) 5-13
28. Hsieh, L. T., Nastase, M. V., Zeng-Brouwers, J., Iozzo, R. V., and Schaefer, L. (2014) Soluble biglycan as a biomarker of inflammatory renal diseases Int. J. Biochem. Cell Biol. 54C, 223-235 10.1016/j.biocel.2014.07.020
29. Brandan, E. and Gutierrez, J. (2013) Role of skeletal muscle proteoglycans during myogenesis Matrix Biol. 32, 289-297 10.1016/j.matbio.2013.03.007
30. Ichii, M., Frank, M. B., Iozzo, R. V., and Kincade, P. W. (2012) The canonical Wnt pathway shapes niches supportive of hematopoietic stem/progenitor cells Blood 119, 1683-1692 10.1182/blood-2011-07-369199
31. Zoeller, J. J., Pimtong, W., Corby, H., Goldoni, S., Iozzo, A. E., Owens, R. T., Ho, S.-Y., and Iozzo, R. V. (2009) A central role for decorin during vertebrate convergent extension J. Biol. Chem. 284, 11728-11737 10.1074/jbc.M808991200
32. Merline, R., Moreth, K., Beckmann, J., Nastase, M. V., Zeng-Brouwers, J., Tralhão, J. G., Lemarchand, P., Pfeilschifter, J., Schaefer, R. M., Iozzo, R. V., and Schaefer, L. (2011) Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and microRNA-21 Sci. Signaling 4, ra75 10.1126/scisignal.2001868
33. Frey, T., Schroeder, N., Manon-Jensen, T., Iozzo, R. V., and Schaefer, L. (2013) Biological interplay between proteoglycans and their innate immune receptors in inflammation FEBS J. 280, 2165-2179 10.1111/febs.12145
34. Zeng-Brouwers, J., Beckmann, J., Nastase, M. V., Iozzo, R. V., and Schaefer, L. (2014) De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88/TRIF pathways Matrix Biol. 35, 132-142 10.1016/j.matbio.2013.12.003
35. Dunkman, A. A., Buckley, M. R., Mienaltowski, M. J., Adams, S. M., Thomas, S. J., Kumar, A., Beason, D. P., Iozzo, R. V., Birk, D. E., and Soslowsky, L. J. (2014) The injury response of aged tendons in the absence of biglycan and decorin Matrix Biol. 35, 232-238 10.1016/j.matbio.2013.10.008
36. Dunkman, A. A., Buckley, M. R., Mienaltowski, M. J., Adams, S. M., Thomas, S. J., Satchell, L., Kumar, A., Pathmanathan, L., Beason, D. P., Iozzo, R. V., Birk, D. E., and Soslowsky, L. J. (2013) Decorin expression is important for age-related changes in tendon structure and mechanical properties Matrix Biol. 32, 3-13 10.1016/j.matbio.2012.11.005
37. Chen, S. C., Young, M. F., Chakravarti, S., and Birk, D. E. (2014) Interclass small leucine-rich repeat proteoglycan interactions regulate collagen fibrillogenesis and corneal stromal assembly Matrix Biol. 35, 103-111 10.1016/j.matbio.2014.01.004
38. Wu, Z., Horgan, C. E., Carr, O., Owens, R. T., Iozzo, R. V., and Lechner, B. E. (2014) Biglycan and decorin differentially regulate signaling in the fetal membranes Matrix Biol. 35, 266-275 10.1016/j.matbio.2013.12.006
39. Wang, H., Listrat, A., Meunier, B., Gueugneau, M., Coudy-Gandilhon, C., Combaret, L., Taillandier, D., Polge, C., Attaix, D., Lethias, C., Lee, K., Goh, K. L., and Bechet, D. (2014) Apoptosis in capillary endothelial cells in ageing skeletal muscle Aging Cell 13, 254-262 10.1111/acel.12169
40. Iozzo, R. V. (2005) Basement membrane proteoglycans: from cellar to ceiling Nat. Rev. Mol. Cell Biol. 6, 646-656 10.1038/nrm1702
41. Whitelock, J. M., Melrose, J., and Iozzo, R. V. (2008) Diverse cell signaling events modulated by perlecan Biochemistry 47, 11174-11183 10.1021/bi8013938
42. Fuki, I. V., Kuhn, K. M., Lomazov, I. R., Rothman, V. L., Tuszynski, G. P., Iozzo, R. V., Swenson, T. L., Fisher, E. A., and Williams, K. J. (1997) The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro J. Clin. Invest. 100, 1611-1622 10.1172/JCI119685
43. Fuki, I., Iozzo, R. V., and Williams, K. J. (2000) Perlecan heparan sulfate proteoglycan. A novel receptor that mediates a distinct pathway for ligand catabolism J. Biol. Chem. 275, 25742-25750 10.1074/jbc.M909173199
44. Christianson, H. C. and Belting, M. (2014) Heparan sulfate proteoglycan as a cell-surface endocytosis receptor Matrix Biol. 35, 51-55 10.1016/j.matbio.2013.10.004
45. Zhang, G., Ezura, Y., Chervoneva, I., Robinson, P. S., Beason, D. P., Carine, E. T., Soslowsky, L. J., Iozzo, R. V., and Birk, D. E. (2006) Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties during tendon development J. Cell. Biochem. 98, 1436-1449 10.1002/jcb.20776
46. Zhang, G., Chen, S., Goldoni, S., Calder, B. W., Simpson, H. C., Owens, R. T., McQuillan, D. J., Young, M. F., Iozzo, R. V., and Birk, D. E. (2009) Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan J. Biol. Chem. 284, 8888-8897 10.1074/jbc.M806590200
47. Chen, S., Sun, M., Meng, X., Iozzo, R. V., Kao, W. W. Y., and Birk, D. E. (2011) Pathophysiological mechanisms of autosomal dominant congenital stromal corneal dystrophy. C-terminal-truncated decorin results in abnormal matrix assembly and altered expression of small leucine-rich proteoglycans Am. J. Pathol. 179, 2409-2419 10.1016/j.ajpath.2011.07.026
48. Chen, S. and Birk, D. E. (2013) The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly FEBS J. 280, 2120-2137 10.1111/febs.12136
49. Cabello-Verrugio, C. and Brandan, E. (2007) A novel modulatory mechanism of transforming growth factor-β signaling through decorin and LRP-1 J. Biol. Chem. 282, 18842-18850 10.1074/jbc.M700243200
50. Buraschi, S., Pal, N., Tyler-Rubinstein, N., Owens, R. T., Neill, T., and Iozzo, R. V. (2010) Decorin antagonizes Met receptor activity and downregulates β-catenin and Myc levels J. Biol. Chem. 285, 42075-42085 10.1074/jbc.M110.172841
51. Buraschi, S., Neill, T., Owens, R. T., Iniguez, L. A., Purkins, G., Vadigepalli, R., Evans, B., Schaefer, L., Peiper, S. C., Wang, Z., and Iozzo, R. V. (2012) Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model PLoS One 7, e45559 10.1371/journal.pone.0045559
52. Neill, T., Painter, H., Buraschi, S., Owens, R. T., Lisanti, M. P., Schaefer, L., and Iozzo, R. V. (2012) Decorin antagonizes the angiogenic network. Concurrent inhibition of Met, hypoxia inducible factor-1α and vascular endothelial growth factor A and induction of thrombospondin-1 and TIMP3 J. Biol. Chem. 287, 5492-5506 10.1074/jbc.M111.283499
53. Patel, S., Santra, M., McQuillan, D. J., Iozzo, R. V., and Thomas, A. P. (1998) Decorin activates the epidermal growth factor receptor and elevates cytosolic Ca2+ in A431 cells J. Biol. Chem. 273, 3121-3124 10.1074/jbc.273.6.3121
54. Zhu, J.-X., Goldoni, S., Bix, G., Owens, R. A., McQuillan, D., Reed, C. C., and Iozzo, R. V. (2005) Decorin evokes protracted internalization and degradation of the EGF receptor via caveolar endocytosis J. Biol. Chem. 280, 32468-32479 10.1074/jbc.M503833200
55. Santra, M., Reed, C. C., and Iozzo, R. V. (2002) Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping with but distinct from the EGF-binding epitope J. Biol. Chem. 277, 35671-35681 10.1074/jbc.M205317200
56. Lemmon, M. A. and Schlessinger, J. (2010) Cell signaling by receptor tyrosine kinases Cell 141, 1117-1134 10.1016/j.cell.2010.06.011
57. Seidler, D. G., Goldoni, S., Agnew, C., Cardi, C., Thakur, M. L., Owens, R. A., McQuillan, D. J., and Iozzo, R. V. (2006) Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation J. Biol. Chem. 281, 26408-26418 10.1074/jbc.M602853200
58. Abulrob, A., Giuseppin, S., Andrade, M. F., McDermid, A., Moreno, M., and Stanimirovic, D. (2004) Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae Oncogene 23, 6967-6979 10.1038/sj.onc.1207911
59. Minor, K. H., Bournat, J. C., Toscano, N., Giger, R. J., and Davies, S. J. A. (2011) Decorin, erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regulation of semaphorin 3A in central nervous system scar tissue Brain 134, 1140-1155 10.1093/brain/awq304
60. Goldoni, S., Humphries, A., Nyström, A., Sattar, S., Owens, R. T., McQuillan, D. J., Ireton, K., and Iozzo, R. V. (2009) Decorin is a novel antagonistic ligand of the Met receptor J. Cell Biol. 185, 743-754 10.1083/jcb.200901129
61. Xu, W., Neill, T., Yang, Y., Hu, Z., Cleveland, E., Wu, Y., Hutten, R., Xiao, X., Stock, S. R., Shevrin, D., Kaul, K., Brendler, C., Iozzo, R. V., and Seth, P. (2015) The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer Gene Ther. 22, 31-40 10.1038/gt.2014.110
62. Neill, T., Jones, H. R., Crane-Smith, Z., Owens, R. T., Schaefer, L., and Iozzo, R. V. (2013) Decorin induces rapid secretion of thrombospondin-1 in basal breast carcinoma cells via inhibition of Ras homolog gene family, member A/Rho-associated coiled-coil containing protein kinase 1 FEBS J. 280, 2353-2368 10.1111/febs.12148
63. Neill, T., Torres, A., Buraschi, S., Owens, R. T., Hoek, J., Baffa, R., and Iozzo, R. V. (2014) Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and mitostatin J. Biol. Chem. 289, 4952-4968 10.1074/jbc.M113.512566
64. Miller, J. K., Shattuck, D., Ingalla, E. Q., Yen, L., Borowsky, A. D., Young, L. J. T., Cardiff, R. D., Carraway, K. L., III, and Sweeney, C. (2008) Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer Cancer Res. 68, 8286-8294 10.1158/0008-5472.CAN-07-6316
65. Fassan, M., D'Arca, D., Letko, J., Vecchione, A., Gardiman, M. P., McCue, P., Wildemore, B., Rugge, M., Shupp-Byrne, D., Gomella, L. G., Morrione, A., Iozzo, R. V., and Baffa, R. (2011) Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells PLoS One 6, e19771 10.1371/journal.pone.0019771
66. Morrione, A., Neill, T., and Iozzo, R. V. (2013) Dichotomy of decorin activity on the insulin-like growth factor-I system FEBS J. 280, 2138-2149 10.1111/febs.12149
67. Schönherr, E., Sunderkötter, C., Iozzo, R. V., and Schaefer, L. (2005) Decorin, a novel player in the insulin-like growth factor system J. Biol. Chem. 280, 15767-15772 10.1074/jbc.M500451200
68. Iozzo, R. V., Buraschi, S., Genua, M., Xu, S.-Q., Solomides, C. C., Peiper, S. C., Gomella, L. G., Owens, R. T., and Morrione, A. (2011) Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling J. Biol. Chem. 286, 34712-34721 10.1074/jbc.M111.262766
69. Fiedler, L. R., Schönherr, E., Waddington, R., Niland, S., Seidler, D. G., Aeschlimann, D., and Eble, J. A. (2008) Decorin regulates endothelial cell motility on collagen I through activation of Insulin-like growth factor I receptor and modulation of α2β1 integrin activity J. Biol. Chem. 283, 17406-17415 10.1074/jbc.M710025200
70. Brandan, E., Cabello-Verrugio, C., and Vial, C. (2008) Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy Matrix Biol. 27, 700-708 10.1016/j.matbio.2008.07.004
71. Vial, C., Gutierrez, J., Santander, C., Cabrera, D., and Brandan, E. (2011) Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity J. Biol. Chem. 286, 24242-24252 10.1074/jbc.M110.189365
72. Schaefer, L., Mihalik, D., Babelova, A., Krzyzankova, M., Grone, H. J., Iozzo, R. V., Young, M. F., Seidler, D. G., Lin, G., Reinhardt, D., and Schaefer, R. M. (2004) Regulation of fibrillin-1 by biglycan and decorin is important for tissue preservation in the kidney during pressure-induced injury Am. J. Pathol. 165, 383-396 10.1016/S0002-9440(10)63305-6
73. Schaefer, L., Tsalastra, W., Babelova, A., Baliova, M., Minnerup, J., Sorokin, L., Gröne, H.-J., Reinhardt, D. P., Pfeilschifter, J., Iozzo, R. V., and Schaefer, R. M. (2007) Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-1 receptor and mammalian target of rapamycin Am. J. Pathol. 170, 301-315 10.2353/ajpath.2007.060497
74. Moreth, K., Iozzo, R. V., and Schaefer, L. (2012) Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation Cell Cycle 11, 2084-2091 10.4161/cc.20316
75. Metalli, D., Lovat, F., Tripodi, F., Genua, M., Xu, S.-Q., Spinelli, M., Alberghina, L., Vanoni, M., Baffa, R., Gomella, L. G., Iozzo, R. V., and Morrione, A. (2010) The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin Am. J. Pathol. 176, 2997-3006 10.2353/ajpath.2010.090904
76. Morcavallo, A., Buraschi, S., Xu, S.-Q., Belfiore, A., Schaefer, L., Iozzo, R. V., and Morrione, A. (2014) Decorin differentially modulates the activity of insulin receptor isoform A ligands Matrix Biol. 35, 82-90 10.1016/j.matbio.2013.12.010
77. Genua, M., Xu, S.-Q., Buraschi, S., Peiper, S. C., Gomella, L. G., Belfiore, A., Iozzo, R. V., and Morrione, A. (2012) Prolyne-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells PLoS One 7, e40148 10.1371/journal.pone.0040148
78. Buraschi, S., Neill, T., Goyal, A., Poluzzi, C., Smythies, J., Owens, R. T., Schaefer, L., Torres, A., and Iozzo, R. V. (2013) Decorin causes autophagy in endothelial cells via Peg3 Proc. Natl. Acad. Sci. U. S. A. 110, E2582-E2591 10.1073/pnas.1305732110
79. Goyal, A., Neill, T., Owens, R. T., Schaefer, L., and Iozzo, R. V. (2014) Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells Matrix Biol. 34, 46-54 10.1016/j.matbio.2013.12.011
80. Nussenzweig, S. C., Verma, S., and Finkel, T. (2015) The role of autophagy in vascular biology Circ. Res. 116, 480-488 10.1161/CIRCRESAHA.116.303805
81. Kim, J., Kundu, M., Viollet, B., and Guan, K.-L. (2011) AMPK and mTOR regulate autophagy through direct phopshorylation of Ulk1 Nat. Cell Biol. 13, 132-141 10.1038/ncb2152
82. Horvath, Z., Kovalszky, I., Fullar, A., Kiss, K., Schaff, Z., Iozzo, R. V., and Baghy, K. (2014) Decorin deficiency promotes hepatic carcinogenesis Matrix Biol. 35, 194-205 10.1016/j.matbio.2013.11.004
83. Baghy, K., Horváth, Z., Regõs, E., Kiss, K., Schaff, Z., Iozzo, R. V., and Kovalszky, I. (2013) Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis FEBS J. 280, 2150-2164 10.1111/febs.12215
84. Iozzo, R. V. (1988) Proteoglycans and neoplasia Cancer Metastasis Rev. 7, 39-50 10.1007/BF00048277
85. Iozzo, R. V., Chakrani, F., Perrotti, D., McQuillan, D. J., Skorski, T., Calabretta, B., and Eichstetter, I. (1999) Cooperative action of germline mutations in decorin and p53 accelerates lymphoma tumorigenesis Proc. Natl. Acad. Sci. U. S. A. 96, 3092-3097 10.1073/pnas.96.6.3092
86. Bi, X., Tong, C., Dockendorff, A., Bancroft, L., Gallagher, L., Guzman-Hartman, G., Iozzo, R. V., Augenlicht, L. H., and Yang, W. (2008) Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation Carcinogenesis 29, 1435-1440 10.1093/carcin/bgn141
87. Bi, X., Pohl, N. M., Yang, G. R., Gou, Y., Guzman, G., Kajdacsy-Balla, A., Iozzo, R. V., and Yang, W. (2012) Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice Carcinogenesis 33, 326-330 10.1093/carcin/bgr293
88. Hildebrand, A., Romaris, M., Rasmussen, L. M., Heinegård, D., Twardzik, D. R., Border, W. A., and Ruoslahti, E. (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor β Biochem. J. 302, 527-534
89. Melchior-Becker, A., Dai, G., Ding, Z., Schafer, L., Schrader, J., Young, M. F., and Fischer, J. W. (2011) Deficiency of biglycan causes cardiac fibroblasts to differentiate into a myofibroblast phenotype J. Biol. Chem. 286, 17365-17375 10.1074/jbc.M110.192682
90. Moreno, M., Muñoz, R., Aroca, F., Labarca, M., Brandan, E., and Larraín, J. (2005) Biglycan is a new extracellular component of the chordin-BMP4 signaling pathway EMBO J. 24, 1397-1405 10.1038/sj.emboj.7600615
91. Berendsen, A. D., Fisher, L. W., Kilts, T. M., Owens, R. T., Robey, P. G., Gutkind, J. S., and Young, M. F. (2011) Modulation of canonical Wnt signaling by the extracellular matrix component biglycan Proc. Natl. Acad. Sci. U. S. A. 108, 17022-17027 10.1073/pnas.1110629108
92. Berendsen, A. D., Pinnow, E. L., Maeda, A., Brown, A. C., McCartney-Francis, N., Kram, V., Owens, R. T., Robey, P. G., Holmbeck, K., de Castro, L. F., Kilts, T. M., and Young, M. F. (2014) Biglycan modulates angiogenesis and bone formation during fracture healing Matrix Biol. 35, 223-231 10.1016/j.matbio.2013.12.004
93. Nikitovic, D., Aggelidakis, J., Young, M. F., Iozzo, R. V., Karamanos, N. K., and Tzanakakis, G. N. (2012) The biology of small leucine-rich proteoglycans in bone pathophysiology J. Biol. Chem. 287, 33926-33933 10.1074/jbc.R112.379602
94. Westermann, D., Mersmann, J., Melchior, A., Freudenberger, T., Petrik, C., Schaefer, L., Lüllmann-Rauch, R., Lettau, O., Jacoby, C., Schrader, J., Brand-Herrmann, S.-M., Young, M. F., Schultheiss, H. P., Levkau, B., Baba, H. A., Unger, T., Zacharowski, K., Tschöpe, C., and Fischer, J. W. (2008) Biglycan is required for adaptive remodeling after myocardial infarction Circulation 117, 1269-1276 10.1161/CIRCULATIONAHA.107.714147
95. Schaefer, L., Babelova, A., Kiss, E., Hausser, H.-J., Baliova, M., Krzyzankova, M., Marsche, G., Young, M. F., Mihalik, D., Götte, M., Malle, E., Schaefer, R. M., and Gröne, H.-J. (2005) The matrix component biglycan is proinflammatory and signals through toll-like receptors 4 and 2 in macrophages J. Clin. Invest. 115, 2223-2233 10.1172/JCI23755
96. Babelova, A., Moreth, K., Tsalastra-Greul, W., Zeng-Brouwers, J., Eickelberg, O., Young, M. F., Bruckner, P., Pfeilschifter, J., Schaefer, R. M., Gröne, H.-J., and Schaefer, L. (2009) Biglycan, a danger signal that activates the NLRP3 inflammasome via Toll-like and P2X receptors J. Biol. Chem. 284, 24035-24048 10.1074/jbc.M109.014266
97. Moreth, K., Frey, H., Hubo, M., Zeng-Brouwers, J., Nastase, M. V., Hsieh, L. T., Haceni, R., Pfeilschifter, J., Iozzo, R. V., and Schaefer, L. (2014) Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury Matrix Biol. 35, 143-151 10.1016/j.matbio.2014.01.010
98. Schaefer, L. and Iozzo, R. V. (2012) Small leucine-rich proteoglycans, at the crossroad of cancer growth and inflammation Curr. Opin. Genet. Dev. 22, 56-57 10.1016/j.gde.2011.12.002
99. Schaefer, L. (2010) Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases Curr. Opin. Pharmacol. 10, 185-190 10.1016/j.coph.2009.11.007
100. Schaefer, L. (2014) Complexity of danger: the diverse nature of damage-associated molecular patterns J. Biol. Chem. 289, 35237-35245 10.1074/jbc.R114.619304
101. Moreth, K., Brodbeck, R., Babelova, A., Gretz, N., Spieker, T., Zeng-Brouwers, J., Pfeilschifter, J., Young, M. F., Schaefer, R. M., and Schaefer, L. (2010) The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis J. Clin. Invest. 120, 4251-4272 10.1172/JCI42213
102. Theocharis, A. D., Skandalis, S. S., Neill, T., Multhaupt, H. A., Hubo, M., Frey, H., Gopal, S., Gomes, A., Afratis, N., Lim, H. C., Couchman, J. R., Filmus, J., Sanderson, R. D., Schaefer, L., Iozzo, R. V., and Karamanos, N. K. (2015) Insights into the key roles of proteoglycans in breast cancer biology and translational medicine Biochim. Biophys. Acta, Rev. Cancer 1855, 276-300 10.1016/j.bbcan.2015.03.006
103. Recktenwald, C. V., Leisz, S., Steven, A., Mimura, K., Müller, A., Wulfänger, J., Kiessling, R., and Seliger, B. (2012) HER-2/neu-mediated dosn-regulation of biglycan associated with altered growth properties J. Biol. Chem. 287, 24320-24329 10.1074/jbc.M111.334425
104. Merline, R., Schaefer, R. M., and Schaefer, L. (2009) The matricellular functions of small leucine-rich proteoglycans (SLRPs). Journal of Cell Communication and Signaling 3, 323-335 10.1007/s12079-009-0066-2
105. Xaus, J., Comalada, M., Cardó, M., Valledor, A. F., and Celada, A. (2001) Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27Kip1 and p21Waf1 Blood 98, 2124-2133 10.1182/blood.V98.7.2124
106. Köninger, J., Giese, N. A., Bartel, M., di Mola, F. F., Berberat, P. O., di Sebastiano, P., Giese, T., Büchler, M. W., and Friess, H. (2006) The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitis J. Clin. Pathol. 59, 21-27 10.1136/jcp.2004.023135
107. Bocian, C., Urbanowitz, A. K., Owens, R. T., Iozzo, R. V., Gotte, M., and Seidler, D. G. (2013) Decorin potentiates interferon-gamma activity in a model of allergic inflammation J. Biol. Chem. 288, 12699-12711 10.1074/jbc.M112.419366
108. Smith, S. M. L., West, L. A., Govindraj, P., Zhang, X., Ornitz, D. M., and Hassell, J. R. (2007) Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors Matrix Biol. 26, 175-184 10.1016/j.matbio.2006.10.012
109. Lord, M. S., Chuang, C. Y., Melrose, J., Davies, M. J., Iozzo, R. V., and Whitelock, J. M. (2014) The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling Matrix Biol. 35, 112-122 10.1016/j.matbio.2014.01.016
110. Willis, C. D., Schaefer, L., and Iozzo, R. V. (2012) The biology of perlecan and its bioactive modules. In Extracellular Matrix: Pathobiology and Signaling (Karamanos, N. K., Ed.) pp 171-184, Walter de Gruyter GmbH & Co. KG, Berlin.
111. Farach-Carson, M. C., Warren, C. R., Harrington, D. A., and Carson, D. D. (2014) Border patrol:Insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders Matrix Biol. 34, 64-79 10.1016/j.matbio.2013.08.004
112. Chuang, C. Y., Lord, M. S., Melrose, J., Rees, M. D., Knox, S. M., Freeman, C., Iozzo, R. V., and Whitelock, J. (2010) Heparan sulfate-dependent signaling of fibroblast growth growth factor 18 by chondrocyte-derived perlecan Biochemistry 49, 5524-5532 10.1021/bi1005199
113. Gonzalez, E. M., Mongiat, M., Slater, S. J., Baffa, R., and Iozzo, R. V. (2003) A novel interaction between perlecan protein core and progranulin: Potential effects on tumor growth J. Biol. Chem. 278, 38113-38116 10.1074/jbc.C300310200
114. Zoeller, J. J., Whitelock, J., and Iozzo, R. V. (2009) Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis Matrix Biol. 28, 284-291 10.1016/j.matbio.2009.04.010
115. San Antonio, J. D., Zoeller, J. J., Habursky, K., Turner, K., Pimtong, W., Burrows, M., Choi, S., Basra, S., Bennett, J. S., DeGrado, W. F., and Iozzo, R. V. (2009) A key role for the integrin α2β1 in experimental and developmental angiogenesis Am. J. Pathol. 175, 1338-1347 10.2353/ajpath.2009.090234
116. Wilusz, R. E., DeFrate, L. E., and Guilak, F. (2012) A biomechanical role for perlecan in the pericellular matrix of articular cartilage Matrix Biol. 31, 320-327 10.1016/j.matbio.2012.05.002
117. Wilusz, R. E., Sanchez-Adams, J., and Guilak, F. (2014) The structure and function of the pericellular matrix of articular cartilage Matrix Biol. 39, 25-32 10.1016/j.matbio.2014.08.009
118. Baker, A. B., Ettenson, D. S., Jonas, M., Nugent, M. A., Iozzo, R. V., and Edelman, E. R. (2008) Endothelial cells provide feedback control for vascular remodeling through a mechanosensitive autocrine TGF-β signaling pathway Circ. Res. 103, 289-297 10.1161/CIRCRESAHA.108.179465
119. Nugent, M. A., Nugent, H. M., Iozzo, R. V., Sanchack, K., and Edelman, E. R. (2000) Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia Proc. Natl. Acad. Sci. U. S. A. 97, 6722-6727 10.1073/pnas.97.12.6722
120. Costell, M., Gustafsson, E., Aszódi, A., Mörgelin, M., Bloch, W., Hunziker, E., Addicks, K., Timpl, R., and Fässler, R. (1999) Perlecan maintains the integrity of cartilage and some basement membranes J. Cell Biol. 147, 1109-1122 10.1083/jcb.147.5.1109
121. Arikawa-Hirasawa, E., Watanabe, E., Takami, H., Hassell, J. R., and Yamada, Y. (1999) Perlecan is essential for cartilage and cephalic development Nat. Genet. 23, 354-358 10.1038/15537
122. Zoeller, J. J., McQuillan, A., Whitelock, J., Ho, S.-Y., and Iozzo, R. V. (2008) A central function for perlecan in skeletal muscle and cardiovascular development J. Cell Biol. 181, 381-394 10.1083/jcb.200708022
123. Mongiat, M., Sweeney, S., San Antonio, J. D., Fu, J., and Iozzo, R. V. (2003) Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan J. Biol. Chem. 278, 4238-4249 10.1074/jbc.M210445200
124. Bix, G., Fu, J., Gonzalez, E., Macro, L., Barker, A., Campbell, S., Zutter, M. M., Santoro, S. A., Kim, J. K., Höök, M., Reed, C. C., and Iozzo, R. V. (2004) Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through the α2β1 integrin J. Cell Biol. 166, 97-109 10.1083/jcb.200401150
125. Zoeller, J. J. and Iozzo, R. V. (2008) Proteomic profiling of endorepellin angiostatic activity on human endothelial cells Proteome Sci. 6, 7 10.1186/1477-5956-6-7
126. Cailhier, J.-F., Sirois, I., Raymond, M.-A., Lepage, S., Laplante, P., Brassard, N., Prat, A., Iozzo, R. V., Pshezhetsky, A. V., and Hebért, M.-J. (2008) Caspase-3 activation triggers extracellular release of cathepsin L and endorepellin proteolysis J. Biol. Chem. 283, 27220-27229 10.1074/jbc.M801164200
127. Jung, M., Lord, M. S., Cheng, B., Lyons, J. G., Alkhouri, H., Hughes, J. M., McCarthy, S. J., Iozzo, R. V., and Whitelock, J. M. (2013) Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: A role in angiogenesis and wound healing J. Biol. Chem. 288, 3289-3304 10.1074/jbc.M112.387811
128. Goyal, A., Pal, N., Concannon, M., Paul, M., Doran, M., Poluzzi, C., Sekiguchi, K., Whitelock, J. M., Neill, T., and Iozzo, R. V. (2011) Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2) J. Biol. Chem. 286, 25947-25962 10.1074/jbc.M111.243626
129. Bix, G., Castello, R., Burrows, M., Zoeller, J. J., Weech, M., Iozzo, R. A., Cardi, C., Thakur, M. T., Barker, C. A., Camphausen, K. C., and Iozzo, R. V. (2006) Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism J.Natl.Cancer Inst. 98, 1634-1646 10.1093/jnci/djj441
130. Bix, G. and Iozzo, R. V. (2008) Novel interactions of perlecan: Unraveling perlecan's role in angiogenesis Microsc. Res. Tech. 71, 339-348 10.1002/jemt.20562
131. Gonzalez, E. M., Reed, C. C., Bix, G., Fu, J., Zhang, Y., Gopalakrishnan, B., Greenspan, D. S., and Iozzo, R. V. (2005) BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan J. Biol. Chem. 280, 7080-7087 10.1074/jbc.M409841200
132. Le, B. V., Kim, H., Choi, J., Kim, J.-H., Hahn, M.-J., Lee, C., Kim, K. K., and Hwang, H.-Y. (2011) Crystal Structure of the LG3 domain of endorepellin, an angiogenesis inhibitor J. Mol. Biol. 414, 231-242 10.1016/j.jmb.2011.09.048
133. Willis, C. D., Poluzzi, C., Mongiat, M., and Iozzo, R. V. (2013) Endorepellin laminin-like globular repeat 1/2 domains bind Ig3-5 of vascular endothelial growth factor(VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells FEBS J. 280, 2271-2294 10.1111/febs.12164
134. Nyström, A., Shaik, Z. P., Gullberg, D., Krieg, T., Eckes, B., Zent, R., Pozzi, A., and Iozzo, R. V. (2009) Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity Blood 114, 4897-4906 10.1182/blood-2009-02-207134
135. Goyal, A., Poluzzi, C., Willis, A. C., Smythies, J., Shellard, A., Neill, T., and Iozzo, R. V. (2012) Endorepellin affects angiogenesis by antagonizing diverse VEGFR2- evoked signaling pathways: transcriptional repression of HIF-1α and VEGFA and concurrent inhibition of NFAT1 activation J. Biol. Chem. 287, 43543-43556 10.1074/jbc.M112.401786
136. Bhattacharya, R., Kwon, J., Wang, E., Mukherjee, P., and Mukhopadhyay, D. (2008) Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF receptor-2 and attenuates endothelial DNA synthesis, but not migration J. Mol. Signaling 3, 8 10.1186/1750-2187-3-8
137. Poluzzi, C., Casulli, J., Goyal, A., Mercer, T. J., Neill, T., and Iozzo, R. V. (2014) Endorepellin evokes autophagy in endothelial cells J. Biol. Chem. 289, 16114-16128 10.1074/jbc.M114.556530
138. Alers, S., Löffler, A. S., Wesselborg, S., and Stork, B. (2012) Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: Crosstalk, shortcuts, and feedbacks Mol. Cell. Biol. 32, 2-11 10.1128/MCB.06159-11
139. West, L., Govindraj, P., Koob, T. J., and Hassell, J. R. (2006) Changes in perlecan during chondrocyte differentiation in the fetal bovine rib growth plate J. Orthop. Res. 24, 1317-1326 10.1002/jor.20160
140. Chang, J. W., Kang, U.-B., Kim, D. H., Yi, J. K., Lee, J. W., Noh, D.-Y., Lee, C., and Yu, M.-H. (2008) Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer Proteomics: Clin. Appl. 2, 23-32 10.1002/prca.200780049
141. Parker, T. J., Sampson, D. L., Broszczak, D., Chng, Y. L., Carter, S. L., Leavesley, D. I., Parker, A. W., and Upton, Z. (2012) A fragment of the LG3 peptide of endorepellin is present in the urine of physically active mining workers: a potential marker of physical activity PLoS One 7, e33714 10.1371/journal.pone.0033714
142. Saini, M. G. and Bix, G. J. (2012) Oxygen-glucose deprivation (OGD) and interleukin-1 (IL-1) differentially modulate cathepsin B/L mediated generation of neuroprotective perlecan LG3 by neurons Brain Res. 1438, 65-74 10.1016/j.brainres.2011.12.027
143. Saini, M. G., Pinteaux, E., Lee, B., and Bix, G. J. (2011) Oxygen-glucose deprivation and interleukin-1α trigger the release of perlecan LG3 by cells of neurovascular unit J. Neurochem. 119, 760-771 10.1111/j.1471-4159.2011.07484.x
144. Soulez, M., Pilon, E.-A., Dieudé, M., Cardinal, H., Brassard, N., Qi, S., Wu, S.-J., Durocher, Y., Madore, F., Perreault, C., and Hébert, M.-J. (2012) The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection Circ. Res. 110, 94-104 10.1161/CIRCRESAHA.111.250431
145. Surin, B., Sachon, E., Rougier, J.-P., Steverlynck, C., Garreau, C., Lelongt, B., Ronco, P., and Piedagnel, R. (2013) LG3 fragment of endorepellin is a possible biomarker of severity in lgA nephropathy Proteomics 13, 142-152 10.1002/pmic.201200267
146. Henry, M. D. and Campbell, K. P. (1999) Dystroglycan inside and out Curr. Opin. Cell Biol. 11, 602-607 10.1016/S0955-0674(99)00024-1
147. Gesemann, M., Brancaccio, A., Schumacher, B., and Ruegg, M. A. (1998) Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue J. Biol. Chem. 273, 600-605 10.1074/jbc.273.1.600
148. Hohenester, E., Tisi, D., Talts, J. F., and Timpl, R. (1999) The crystal structure of a laminin G-like module reveals the molecular basis of α-dystroglycan binding to laminins, perlecan, and agrin Mol. Cell 4, 783-792 10.1016/S1097-2765(00)80388-3
149. Ida-Yonemochi, H., Ahsan, M. S., and Saku, T. (2011) Differential expression profiles between α-dystroglycan and integrin β1 in ameloblastoma: two possible perlecan signalling pathways for cellular growth and differentiation Histopathology 58, 234-245 10.1111/j.1365-2559.2010.03732.x
150. Kanagawa, M., Michele, D. E., Satz, J. S., Barresi, R., Kusano, H., Sasaki, T., Timpl, R., Henry, M. D., and Campbell, K. P. (2005) Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function FEBS Lett. 579, 4792-4796 10.1016/j.febslet.2005.07.059
151. Colombelli, C., Palmisano, M., Eshed-Eisenbach, Y., Zambroni, D., Pavoni, E., Ferri, C., Saccucci, S., Nicole, S., Soininen, R., McKee, K. K., Yurchenco, P. D., Peles, E., Wrabetz, L., and Feltri, M. L. (2015) Perlecan is recruited by dystroglycan to nodes of Ranvier and binds the clustering molecule gliomedin J. Cell Biol. 208, 313-329 10.1083/jcb.201403111
152. Lin, S., Maj, M., Bezakova, G., Magyar, J. P., Brenner, H. R., and Ruegg, M. A. (2008) Muscle-wide secretion of a miniaturized form of neural agrin rescues focal neuromuscular innervation in agrin mutant mice Proc. Natl. Acad. Sci. U. S. A. 105, 11406-11411 10.1073/pnas.0801683105
153. Stetefeld, J., Alexandrescu, A. T., Maciejewski, M. W., Jenny, M., Rathgeb-Szabo, K., Schulthess, T., Landwehr, R., Frank, S., Ruegg, M. A., and Kammerer, R. A. (2004) Modulation of agrin function by alternative splicing and Ca2+ binding Structure 12, 503-515 10.1016/j.str.2004.02.001
154. Neumann, F. R., Bittcher, G., Annies, M., Schumacher, B., Kröger, S., and Ruegg, M. A. (2001) An alternative amino-terminus expressed in the central nervous system converts agrin to a type II transmembrane protein Mol. Cell. Neurosci. 17, 208-225 10.1006/mcne.2000.0932
155. Ramseger, R., White, R., and Kröger, S. (2009) Transmembrane form agrin-induced process formation requires lipid rafts and the activation of Fyn and MAPK J. Biol. Chem. 284, 7697-7705 10.1074/jbc.M806719200
156. Bezakova, G. and Rüegg, M. A. (2003) New insights into the roles of agrin Nat. Rev. Mol. Cell Biol. 4, 295-308 10.1038/nrm1074
157. Kim, M. J., Liu, I.-H., Song, Y., Lee, J.-A., Halfter, W., Balice-Gordon, R. J., Linney, E., and Cole, G. J. (2006) Agrin is required for posterior development and motor axon outgrowth and branching in embryonic zebrafish Glycobiology 17, 231-247 10.1093/glycob/cwl069
158. Kim, M. J., Cotman, S. L., Halfter, W., and Cole, G. (2003) The heparan sulfate proteoglycan agrin modulates neurite outgrowth mediated by FGF-2 J. Neurobiol. 55, 261-277 10.1002/neu.10213
159. Liu, I.-H., Zhang, C., Kim, J. M., and Cole, G. J. (2008) Retina development in zebrafish requires the heparan sulfate proteoglycan agrin Dev. Neurobiol. 68, 877-898 10.1002/dneu.20625
160. Kawahara, R., Granato, D. C., Carnielli, C. M., Cervigne, N. K., Oliveria, C. E., Martinez, C. A., Yokoo, S., Fonseca, F. P., Lopes, M., Santos-Silva, A. R., Graner, E., Coletta, R. D., and Paes Leme, A. F. (2014) Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma PLoS One 9, e115004 10.1371/journal.pone.0115004
161. Tátrai, P., Dudás, J., Batmunkh, E., Máthé, M., Zalatnai, A., Schaff, Z., Ramadori, G., and Kovalszky, I. (2006) Agrin, a novel basement membrane component in human rat and liver, accumulates in cirrhosis and hepatocellular carcinoma Lab. Invest. 86, 1149-1160 10.1038/labinvest.3700475
162. Batmunkh, E., Tátrai, P., Szabó, E., Lódi, C., Holczbauer, A., Páska, C., Kupcsulik, P., Kiss, A., Schaff, Z., and Kovalszky, I. (2007) Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma Hum. Pathol. 38, 1508-1515 10.1016/j.humpath.2007.02.017
163. Patel, T. R., Butler, G., McFarlane, A., Xie, I., Overall, C. M., and Stetefeld, J. (2012) Site specific cleavage mediated by MMPs regulates function of agrin PLoS One 7, e43669 10.1371/journal.pone.0043669
164. Stephan, A., Mateos, J. M., Kozlov, S. V., Cinelli, P., Kistler, A. D., Hettwer, S., Rülicke, T., Streit, P., Kunz, B., and Sonderegger, P. (2008) Neurotrypsin cleaves agrin locally at the synapse FASEB J. 22, 1861-1873 10.1096/fj.07-100008
165. Reif, R., Sales, S., Hettwer, S., Dreier, B., Gisler, C., Wölfel, J., Lüscher, D., Zurlinden, A., Stephan, A., Ahmed, S., Baici, A., Ledermann, B., Kunz, B., and Sonderegger, P. (2007) Specific cleavage of agrin by neurotrypsin, a synaptic protease linked to mental retardation FASEB J. 21, 3468-3478 10.1096/fj.07-8800com
166. O'Toole, J. J., Deyst, K. A., Bowe, M. A., Nastuk, M. A., McKechnie, B. A., and Fallon, J. A. (1996) Alternative splicing of agrin regulates its binding to heparin, α-dystroglycan, and the cell surface Proc. Natl. Acad. Sci. U. S. A. 93, 7369-7374 10.1073/pnas.93.14.7369
167. Yamada, H., Denzer, A. J., Hori, H., Tanaka, T., Anderson, L. V. B., Fujita, S., Fukuta-Oh, H., Shimizu, T., Ruegg, M. A., and Matsumura, K. (1996) Dystroglycan is a dual receptor for agrin and laminin-2 in schwann cell membrane J. Biol. Chem. 271, 23418-23423 10.1074/jbc.271.38.23418
168. Godfrey, C., Foley, A. R., Clement, E., and Muntoni, F. (2011) Dystroglycanopathies: coming into focus Curr. Opin. Genet. Dev. 21, 278-285 10.1016/j.gde.2011.02.001
169. Peng, H. B., Xie, H., Rossi, S. G., and Rotundo, R. L. (1999) Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan J. Cell Biol. 145, 911-921 10.1083/jcb.145.4.911
170. Pribiag, H., Peng, H., Shah, W. A., Stellwagen, D., and Carbonetto, S. (2014) Dystroglycan mediates homeostatic synaptic plasticity at GABAergic synapses Proc. Natl. Acad. Sci. U. S. A. 111, 6810-6815 10.1073/pnas.1321774111
171. Scotton, P., Bleckmann, D., Stebler, M., Sciandra, F., Brancaccio, A., Meier, T., Stetefeld, J., and Ruegg, M. A. (2006) Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin J. Biol. Chem. 281, 36835-36845 10.1074/jbc.M607887200
172. Zhang, J., Wang, Y., Chu, Y., Su, L., Gong, Y., Zhang, R., and Xiong, S. (2006) Agrin is involved in lymphocytes activation that is mediated by α-dystroglycan FASEB J. 20, 50-58 10.1096/fj.04-3303com
173. Mazzon, C., Anselmo, A., Soldani, C., Cibella, J., Ploia, C., Moalli, F., Burden, S. J., Dustin, M. L., Sarukhan, A., and Viola, A. (2012) Agrin is required for survival and function of monocytic cells Blood 119, 5502-5511 10.1182/blood-2011-09-382812
174. Hilgenberg, L. G. W., Su, H., Gu, H., O'Dowd, D. K., and Smith, M. A. (2006) α3Na+/K+-ATPase is a neuronal receptor for agrin Cell 125, 359-369 10.1016/j.cell.2006.01.052
175. Burgess, R. W., Dickman, D. K., Nunez, L., Glass, D. J., and Sanes, J. R. (2002) Mapping sites responsible for interactions of agrin with neurons J. Neurochem. 83, 271-284 10.1046/j.1471-4159.2002.01102.x
176. Martin, P. T. and Sanes, J. R. (1997) Integrins mediate adhesion to agrin and modulate agrin signaling Development 124, 3909-3917
177. Kim, N., Stiegler, A. L., Cameron, T. O., Hallock, P. T., Gomez, A. M., Huang, J. H., Hubbard, S. R., Dustin, M. L., and Burden, S. J. (2008) Lrp4 is a receptor for agrin and forms a complex with MuSK Cell 135, 334-342 10.1016/j.cell.2008.10.002
178. Chakraborty, S., Lakshmanan, M., Swa, H. L., Chen, J., Zhang, X., Ong, Y. S., Loo, L. S., Akincilar, S. C., Gunaratne, J., Tergaonkar, V., Hui, K. M., and Hong, W. (2015) An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma Nat. Commun. 6, 6184 10.1038/ncomms7184
179. Vuadens, F., Benay, C., Crettaz, D., Gallot, D., Sapin, V., Schneider, P., Binevenut, W.-V., Lémery, D., Quadroni, M., Dastugue, B., and Tissot, J.-D. (2003) Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach Proteomics 3, 1521-1525 10.1002/pmic.200300455
180. Halfter, W. and Schurer, B. (1994) A new heparan sulfate proteoglycan in the extracellular matrix of the developing chick embryo Exp. Cell Res. 214, 285-296 10.1006/excr.1994.1260
181. Marneros, A. G. and Olsen, B. R. (2005) Physiological role of collagen XVIII and endostatin FASEB J. 19, 716-728 10.1096/fj.04-2134rev
182. Dong, S., Cole, G. J., and Halfter, W. (2003) Expression of collagen XVIII and localization of its glycosaminoglycan attachment sites J. Biol. Chem. 278, 1700-1707 10.1074/jbc.M209276200
183. Fukai, N., Eklund, L., Marneros, A. G., Oh, S. P., Keene, D. R., Tamarkin, L., Niemelä, M., Ilves, M., Li, E., Pihlajaniemi, T., and Olsen, B. R. (2002) Lack of collagen XVIII/endostatin results in eye abnormalities EMBO J. 21, 1535-1544 10.1093/emboj/21.7.1535
184. Utriainen, A., Sormunen, R., Kettunen, M., Carvalhaes, L. S., Sajanti, E., Eklund, L., Kauppinen, R., Kitten, G. T., and Pihlajaniemi, T. (2004) Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line Hum. Mol. Genet. 13, 2089-2099 10.1093/hmg/ddh213
185. Bishop, J. R., Passos-Bueno, M. R., Fong, L., Stanford, K. I., Gonzales, J. C., Yeh, E., Young, S. G., Bensadoun, A., Wizemann, H., Esko, J. D., and Moulton, K. S. (2010) Deletion of basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans PLoS One 5, e13919 10.1371/journal.pone.0013919
186. Zeng, X., Chen, J., Miller, Y. I., Javaherian, K., and Moulton, K. S. (2005) Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis J. Lipid Res. 46, 1849-1859 10.1194/jlr.M500241-JLR200
187. Marneros, A. G., Keene, D. R., Hansen, U., Fukai, N., Moulton, K., Goletz, P. L., Moiseyev, G., Pawlyk, B. S., Halfter, W., Dong, S., Shibata, M., Li, T., Crouch, R. K., Bruckner, P., and Olsen, B. R. (2004) Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function EMBO J. 23, 89-99 10.1038/sj.emboj.7600014
188. Moulton, K. S., Olsen, B. R., Sonn, S., Fukai, N., Zurakowski, D., and Zeng, X. (2004) Loss of collagen XVIII enhances neovascularization and vascular permeability in atherosclerosis Circulation 110, 1330-1336 10.1161/01.CIR.0000140720.79015.3C
189. Musso, O., Rehn, M., Théret, N., Turlin, B., Bioulac-Sage, P., Lotrian, D., Campion, J.-P., Pihlajaniemi, T., and Clément, B. (2001) Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas Cancer Res. 61, 45-49
190. Zatterstrom, U. K., Felbor, U., Fukai, N., and Olsen, B. R. (2000) Collagen XVIII/endostatin structure and functional role in angiogenesis Cell Struct. Funct. 25, 97-101 10.1247/csf.25.97
191. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88, 277-285 10.1016/S0092-8674(00)81848-6
192. Cho, H., Kim, W. J., Lee, Y. M., Kin, Y. M., Kwon, Y. G., Park, Y. S., Choi, E. Y., and Kim, K. W. (2004) N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent Oncol. Rep. 11, 191-195 10.3892/or.11.1.191
193. Parangi, S., O'Reilly, M., Christofori, G., Holmgren, L., Grosfeld, J., Folkman, J., and Hanahan, D. (1996) Antiangiogenic therapy of transgenic mice impairs de novo tumor growth Proc. Natl. Acad. Sci. U. S. A. 93, 2002-2007 10.1073/pnas.93.5.2002
194. Ferreras, M., Felbor, U., Lenhard, T., Olsen, B. R., and Delaisse, J. (2000) Generation and degradation of human endostatin proteins by various proteinases FEBS Lett. 486, 247-251 10.1016/S0014-5793(00)02249-3
195. Felbor, U., Dreier, L., Bryant, R. A. R., Ploegh, H. L., Olsen, B. R., and Mothes, W. (2000) Secreted cathepsin L generates endostatin from collagen XVIII EMBO J. 19, 1187-1194 10.1093/emboj/19.6.1187
196. Wen, W., Moses, M. A., Wiederschain, D., Arbiser, J. L., and Folkman, J. (1999) The generation of endostatin is mediated by elastase Cancer Res. 59, 6052-6056
197. Folkman, J. (2007) Is angiogenesis an organizing principle in biology and medicine? J.Pediatr.Surg. 42, 1-11 10.1016/j.jpedsurg.2006.09.048
198. Kuo, C. J., LaMontagne, K. R., Garcia-Cardena, G., Ackley, B. D., Kalman, D., Park, S., Christofferson, R., Kamihara, J., Ding, Y.-H., Lo, K.-M., Gillies, S., Folkman, J., Mulligan, R. C., and Javaherian, K. (2001) Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NC1/endostatin domain J. Cell Biol. 152, 1233-1246 10.1083/jcb.152.6.1233
199. Abdollahi, A., Hahnfeldt, P., Maercker, C., Gröne, H.-J., Debus, J., Ansorge, W., Folkman, J., Hlatky, L., and Huber, P. E. (2004) Endostatin's antioangiogenic signaling network Mol. Cell 13, 649-663 10.1016/S1097-2765(04)00102-9
200. Boehm, T., O'Reilly, M. S., Keough, K., Shiloach, J., Shapiro, R., and Folkman, J. (1998) Zinc-binding of endostatin is essential for its antiangiogenic activity Biochem. Biophys. Res. Commun. 252, 190-194 10.1006/bbrc.1998.9617
201. Tjin Tham Sjin, R. M., Satchi-Fainaro, R., Birsner, A. E., Ramanujam, V. M., Folkman, J., and Javaherian, K. (2005) A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity Cancer Res. 65, 3656-3663 10.1158/0008-5472.CAN-04-1833
202. Rehn, M., Veikkola, T., Kukk-Valdre, E., Nakamura, H., Ilmonen, M., Lombardo, C. R., Pihlajaniemi, T., Alitalo, K., and Vuori, K. (2001) Interaction of endostatin with integrins implicated in angiogenesis Proc. Natl. Acad. Sci. U. S. A. 98, 1024-1029 10.1073/pnas.98.3.1024
203. Sudhakar, A., Sugimoto, H., Yang, C., Lively, J., Zeisberg, M., and Kalluri, R. (2003) Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins Proc. Natl. Acad. Sci. U. S. A. 100, 4766-4771 10.1073/pnas.0730882100
204. Karumanchi, S. A., Jha, V., Ramchandran, R., Karihaloo, A., Tsiokas, L., Chan, B., Dhanabai, M., Hanai, J.-C., Venkataraman, G., Shriver, Z., Keiser, N., Kalluri, R., Zeng, H., Mukhopadhyay, D., Chen, R. L., Lander, A. D., Hagihara, K., Yamaguchi, Y., Sasisekarharan, R., Cantley, L., and Sukhatme, V. P. (2001) Cell surface glypicans are low-affinity endostatin receptors Mol. Cell 7, 811-822 10.1016/S1097-2765(01)00225-8
205. Kim, Y.-M., Hwang, S., Kim, Y.-M., Pyun, B.-J., Kim, T.-Y., Lee, S.-T., Gho, Y. S., and Kwon, Y.-G. (2002) Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1 J. Biol. Chem. 277, 27872-27879 10.1074/jbc.M202771200
206. Shichiri, M. and Hirata, Y. (2001) Antiangiogenesis signals by endostatin FASEB J. 15, 1044-1053 10.1096/fj.99-1083com
207. Nguyen, T. M. B., Subramanian, I. V., Xiao, X., Ghosh, G., Nguyen, P., Kelekar, A., and Ramakrishnan, S. (2009) Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and β-catenin levels J.Cell.Mol.Med. 13, 3687-3698 10.1111/j.1582-4934.2009.00722.x
208. Chau, Y.-P., Lin, J.-Y., Chen, J.H.-C., and Tai, M.-H. (2003) Endostatin induces autophagic cell death in EAhy926 human endothelial cells Histol.Histopathol 18, 715-726
209. Lee, S.-J., Kim, H. P., Jin, Y., Choi, A. M. K., and Ryter, S. W. (2011) Beclin 1 deficiency is associated with increased hypoxia-induced angiogenesis Autophagy 7, 829-839 10.4161/auto.7.8.15598
210. Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., and Levine, B. (1999) Induction of autophagy and inhibition of tumorigenesis by beclin 1 Nature 402, 672-676 10.1038/45257
211. Nikitovic, D., Papoutsidakis, A., Karamanos, N., and Tzanakasis, G. N. (2014) Lumican affects tumor cell functions, tumor-ECM interactions, angiogenesis and inflammatory response Matrix Biol. 35, 206-214 10.1016/j.matbio.2013.09.003
212. Yamanaka, O., Yuan, Y., Coulson-Thomas, V. J., Gesteira, T. F., Call, M. K., Zhang, Y., Zhang, J., Chang, S. H., Xie, C., Liu, C. Y., Saika, S., Jester, J. V., and Kao, W. W. (2013) Lumican binds ALK5 to promote epithelium wound healing PLoS One 8, e82730 10.1371/journal.pone.0082730